BIOMAT Database Logo BIOMAT Database Logo

Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives. 2014

Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Organic Chemistry Division, Central Leather Research Institute (CSIR), Chennai 600 020, India. Electronic address: t_sree_latha@yahoo.com.

A series of novel naphthoquinone amide derivatives of the bioactive quinones, plumbagin, juglone, menadione and lawsone, with various amino acids were synthesized. The compounds were characterized by (1)H NMR, (13)C NMR, Mass, IR and elemental analysis. All the compounds were evaluated for their anticancer activity against HeLa and SAS cancer cell lines and 3D-QSAR indicated the presence of electron donating group near sulphur enhanced the activity against HeLa cells. Among the derivatives synthesized, compounds 11f, 10a, 10b and 10g were the most active with IC50 values of 16, 12, 14 and 24.5 μM, respectively. The analogues were also screened for antimicrobial activity against two human bacterial pathogens, the Gram-positive Methicillin resistant Staphylococcus aureus (MRSA) and the Gram-negative Pseudomonas aeruginosa and a human yeast pathogen, Fluconazole resistant Candida albicans (FRCA). Among the synthesized compounds, 8g, 10g and 11g exhibited maximum antibacterial activity towards MRSA and antifungal activity against FRCA in well diffusion method.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Design, Synthesis, SAR Study, Antimicrobial and Anticancer Evaluation of Novel 2-Mercaptobenzimidazole Azomethine Derivatives.
January 2020, Mini reviews in medicinal chemistry,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Synthesis and biological evaluation of novel naphthoquinone derivatives as potential anticancer and antimicrobial agents.
October 2004, Bollettino chimico farmaceutico,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Design, synthesis and SAR study of novel trisubstituted pyrimidine amide derivatives as CCR4 antagonists.
March 2014, Molecules (Basel, Switzerland),
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
September 2014, European journal of medicinal chemistry,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.
March 2009, European journal of medicinal chemistry,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Design, synthesis and anticancer activity of naphthoquinone derivatives.
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Synthesis and SAR Study of the Novel Thiadiazole-Imidazole Derivatives as a New Anticancer Agents.
January 2016, Chemical & pharmaceutical bulletin,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Design, synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antifungal and anticancer agents.
March 2004, Bioorganic & medicinal chemistry letters,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents.
June 2004, Bioorganic & medicinal chemistry letters,
Thonthula Sreelatha, and Subramani Kandhasamy, and Raghu Dinesh, and Suresh Shruthy, and Sinha Shweta, and Doble Mukesh, and Devarajan Karunagaran, and Ravichandran Balaji, and Narayanasamy Mathivanan, and Paramasivan Thirumalai Perumal
Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
November 2009, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!